Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 10 studies | 24% ± 9% | |
astrocyte | 7 studies | 25% ± 7% | |
macrophage | 5 studies | 33% ± 12% | |
oligodendrocyte precursor cell | 4 studies | 17% ± 2% | |
glutamatergic neuron | 4 studies | 52% ± 21% | |
classical monocyte | 3 studies | 23% ± 7% | |
hematopoietic precursor cell | 3 studies | 27% ± 7% | |
endothelial cell | 3 studies | 29% ± 10% | |
myeloid cell | 3 studies | 28% ± 6% | |
epithelial cell | 3 studies | 22% ± 7% | |
GABAergic neuron | 3 studies | 43% ± 11% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 6% | |
monocyte | 3 studies | 23% ± 6% | |
transit amplifying cell | 3 studies | 27% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 743.80 | 1439 / 1445 | 100% | 21.91 | 183 / 183 |
bladder | 100% | 982.52 | 21 / 21 | 99% | 28.96 | 501 / 504 |
lung | 100% | 1122.12 | 576 / 578 | 100% | 21.41 | 1151 / 1155 |
intestine | 100% | 869.57 | 964 / 966 | 99% | 18.87 | 524 / 527 |
breast | 100% | 879.91 | 458 / 459 | 99% | 22.92 | 1105 / 1118 |
skin | 99% | 975.40 | 1794 / 1809 | 99% | 32.23 | 469 / 472 |
thymus | 100% | 1402.78 | 653 / 653 | 99% | 17.69 | 596 / 605 |
kidney | 100% | 880.24 | 89 / 89 | 96% | 10.98 | 868 / 901 |
uterus | 94% | 557.33 | 160 / 170 | 99% | 20.85 | 454 / 459 |
stomach | 93% | 515.79 | 333 / 359 | 99% | 17.93 | 284 / 286 |
prostate | 98% | 681.47 | 241 / 245 | 92% | 9.75 | 461 / 502 |
brain | 87% | 790.77 | 2293 / 2642 | 100% | 19.47 | 702 / 705 |
adrenal gland | 100% | 1051.96 | 258 / 258 | 75% | 6.67 | 172 / 230 |
ovary | 67% | 272.31 | 121 / 180 | 99% | 19.47 | 427 / 430 |
liver | 82% | 419.53 | 185 / 226 | 72% | 8.43 | 291 / 406 |
pancreas | 49% | 165.32 | 162 / 328 | 96% | 14.47 | 170 / 178 |
adipose | 100% | 1090.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.82 | 29 / 29 |
muscle | 100% | 1273.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1806.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.40 | 1 / 1 |
blood vessel | 100% | 1594.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 19.87 | 78 / 80 |
peripheral blood | 96% | 1517.89 | 889 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 633.89 | 809 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905461 | Biological process | positive regulation of vascular associated smooth muscle cell apoptotic process |
GO_0070345 | Biological process | negative regulation of fat cell proliferation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006606 | Biological process | protein import into nucleus |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001216 | Molecular function | DNA-binding transcription activator activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | E2F3 |
Protein name | Transcription factor E2F3 (E2F-3) E2F transcription factor 3 isoform d E2F transcription factor 3 isoform c E2F3 protein |
Synonyms | KIAA0075 |
Description | FUNCTION: Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F3 binds specifically to RB1 in a cell-cycle dependent manner. Inhibits adipogenesis, probably through the repression of CEBPA binding to its target gene promoters (By similarity). . |
Accessions | A0A3S9X9Y1 ENST00000535432.2 [O00716-2] Q24JQ3 Q499G5 ENST00000346618.8 [O00716-1] A0A3Q9JIX6 O00716 |